Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Biliary tract cancer

  • You have access
    Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer
    SHOZO MORI, TAKU AOKI, TAKAYUKI SHIRAKI, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, YUHKI SAKURAOKA, YUKIHIRO ISO and KEIICHI KUBOTA
    Anticancer Research October 2021, 41 (10) 5231-5240; DOI: https://doi.org/10.21873/anticanres.15342
  • You have access
    Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection
    MASASHI UTSUMI, KOJI KITADA, NAOYUKI TOKUNAGA, YUSUKE YOSHIDA, TORU NARUSAKA, RYOSUKE HAMANO, HIDEAKI MIYASOU, YOUSUKE TSUNEMITSU, SHINYA OTSUKA and MASARU INAGAKI
    Anticancer Research April 2021, 41 (4) 2147-2155; DOI: https://doi.org/10.21873/anticanres.14987
  • You have access
    Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
    MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI
    Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
  • You have access
    Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
    ALESSANDRO RIZZO, ANGELA DALIA RICCI, NASTASSJA TOBER, MARIA CONCETTA NIGRO, MIRTA MOSCA, ANDREA PALLONI, FRANCESCA ABBATI, GIORGIO FREGA, STEFANIA DE LORENZO, SIMONA TAVOLARI and GIOVANNI BRANDI
    Anticancer Research June 2020, 40 (6) 3013-3030; DOI: https://doi.org/10.21873/anticanres.14282
  • You have access
    Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8+ T Cells in Biliary Tract Cancer
    RYOTA TANAKA, KENJIRO KIMURA, SHINPEI EGUCHI, JUN TAUCHI, MASATUNE SHIBUTANI, HIROJI SHINKAWA, GO OHIRA, SADAAKI YAMAZOE, SHOGO TANAKA, RYOSUKE AMANO, HIROAKI TANAKA, MASAKAZU YASHIRO, SHOJI KUBO and MASAICHI OHIRA
    Anticancer Research May 2020, 40 (5) 2881-2887; DOI: https://doi.org/10.21873/anticanres.14264
  • You have access
    Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases
    KOUSHIRO OHTSUBO, KUNIO MIYAKE, SACHIKO ARAI, KOJI FUKUDA, NAOHIRO YANAGIMURA, CHIAKI SUZUKI, SAKIKO OTANI, YUTA ADACHI, AZUSA TANIMOTO, AKIHIRO NISHIYAMA, KANAME YAMASHITA, SHINJI TAKEUCHI, KENJI NOTOHARA, KENICHI YOSHIMURA and SEIJI YANO
    Anticancer Research October 2019, 39 (10) 5449-5459; DOI: https://doi.org/10.21873/anticanres.13738
  • You have access
    The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer
    NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, YOSHIYA YAMAUCHI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE
    Anticancer Research March 2018, 38 (3) 1755-1761;
  • You have access
    Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases
    NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE
    Anticancer Research July 2017, 37 (7) 3711-3715;
  • You have access
    Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer
    TETSUZO TAGAWA, KENSAKU ITO, KENGO FUKUZAWA, TATSURO OKAMOTO, ATSURO YOSHIMURA, TAKAHIDE KAWASAKI, TAKASHI MASUDA, KENTARO IWAKI, TAKAHIRO TERASHI, MASAHIRO OKAMOTO, AKIO SHIROMIZU, AKIRA MOTOHIRO and YOSHIHIKO MAEHARA
    Anticancer Research March 2017, 37 (3) 1413-1416;
  • You have access
    Multicenter Phase II Clinical Trial of Genexol-PMĀ® with Gemcitabine in Advanced Biliary Tract Cancer
    JIN YOUNG KIM, YOUNG ROK DO, HONG SUK SONG, YOON YOUNG CHO, HUN MO RYOO, SUNG HWA BAE, JONG GWANG KIM, YEE SOO CHAE, BYUNG WOOG KANG, JIN HO BAEK, MIN KYOUNG KIM, KYUNG HEE LEE and KEONUK PARK
    Anticancer Research March 2017, 37 (3) 1467-1473;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire